Society for Endocrinology
7
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
CORE Study - Research Into Weight Management Services in the UK
Role: lead
National Study of Adrenal Tumours
Role: lead
Study of UK Adults With Congenital Adrenal Hyperplasia.
Role: collaborator
In Vivo Succinate Detection After External Beam Radiation Therapy in SDHx- Paragangliomas
Role: collaborator
HIT on Hypoglycaemic Risk in T1D
Role: collaborator
HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)
Role: collaborator
Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome
Role: collaborator
All 7 trials loaded